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on specific neuronal and dendro-synaptic changes in key 
regions resulting in executive dysfunction and other cog-
nitive deficits, which define VCI and VaD, needs to be 
gathered. Hereditary arteriopathies such as cerebral auto-
somal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy or CADASIL have provided insights 
into the mechanisms of dementia associated with cerebral 
small vessel disease. Greater understanding of the neuro-
chemical and molecular investigations is needed to bet-
ter define microvascular disease and vascular substrates 
of dementia. The investigation of relevant animal models 
would be valuable in exploring the pathogenesis as well as 
prevention of the vascular causes of cognitive impairment.
Keywords Alzheimer’s disease · Cerebral amyloid 
angiopathy · Cerebrovascular degeneration · Dementia · 
Neuropathology · Small vessel disease · Vascular dementia
Introduction
Cerebrovascular disease (CVD) is the second most com-
mon cause of age-related cognitive impairment and demen-
tia, which is widely recognised as vascular dementia (VaD). 
VaD culminates from global or localised effects of vascular 
disease, which incurs stroke injury and other tissue perfu-
sion changes. VaD is characterised as a neurocognitive dis-
order, but also incorporates behavioural symptoms, loco-
motor abnormalities and autonomic dysfunction. Vascular 
cognitive impairment (VCI) results from all causes of CVD 
including cardiovascular that lead to early and late plus 
severe forms of dementia syndromes. Within CVD, the 
most common vascular contributor to dementia is likely 
cerebral small vessel disease (SVD), which describes a 
range of clinical, neuroimaging and pathological features. 
Abstract Vascular dementia (VaD) is recognised as a 
neurocognitive disorder, which is explained by numerous 
vascular causes in the general absence of other patholo-
gies. The heterogeneity of cerebrovascular disease makes 
it challenging to elucidate the neuropathological sub-
strates and mechanisms of VaD as well as vascular cogni-
tive impairment (VCI). Consensus and accurate diagnosis 
of VaD relies on wide-ranging clinical, neuropsychometric 
and neuroimaging measures with subsequent pathological 
confirmation. Pathological diagnosis of suspected clinical 
VaD requires adequate postmortem brain sampling and rig-
orous assessment methods to identify important substrates. 
Factors that define the subtypes of VaD include the nature 
and extent of vascular pathologies, degree of involvement 
of extra and intracranial vessels and the anatomical loca-
tion of tissue changes. Atherosclerotic and cardioembolic 
diseases appear the most common substrates of vascular 
brain injury or infarction. Small vessel disease character-
ised by arteriolosclerosis and lacunar infarcts also causes 
cortical and subcortical microinfarcts, which appear to be 
the most robust substrates of cognitive impairment. Diffuse 
WM changes with loss of myelin and axonal abnormalities 
are common to almost all subtypes of VaD. Medial tempo-
ral lobe and hippocampal atrophy accompanied by variable 
hippocampal sclerosis are also features of VaD as they are 
of Alzheimer’s disease. Recent observations suggest that 
there is a vascular basis for neuronal atrophy in both the 
temporal and frontal lobes in VaD that is entirely inde-
pendent of any Alzheimer pathology. Further knowledge 
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SVD has taken precedence as a radiological concept, 
but refers to an intracranial disorder that encompasses 
pathological changes within and at the surfaces of brain 
microvessels including perforating arteries and arterioles, 
capillaries and venules. SVD involves tissue injury in both 
the cortical and subcortical grey and white matter (WM). 
SVD, however, may often coexist with atherosclerosis 
involving large extracranial vessels and embolic disease 
[103].
In this article, I review the brief history of our current 
understanding of VaD, various criteria incorporating clini-
cal, neuropsychological and pathological features that have 
been proposed over the years and key vascular lesions and 
tissue changes, which contribute to dementia. I convey 
some opinions about brain sampling and consider some 
of the rarer causes of VCI and VaD and how these can be 
investigated. It is clear that despite the strong and unam-
biguous evidence that vascular factors and vascular disease 
contribute to the global burden of brain disease, dementia 
prognosis and research has mostly focused on Alzheimer’s 
disease (AD). Vascular causes of dementia and their con-
tribution to neurodegenerative processes have not been 
widely emphasised.
Historical aspects and nosology
One could begin with Thomas Willis and apoplexy, but 
the concept that gradual strangulation of the brain causes 
cognitive and behavioural deficits was distinguished just 
over 100 years ago [18]. Both Alzheimer and Kraeplin had 
reasoned that old age-associated progressive hardening of 
the arteries lead to arteriosclerotic dementia. The label arte-
riosclerotic dementia attributed to cerebral softening with 
loss of relatively large volume (50–100 mL) of brain tissue 
was used in hospital records as late as the 1960s [165]. The 
diagnosis of arteriosclerotic dementia often superseded that 
of AD, which became to be frequently diagnosed in the late 
1970s on whether it is a form of pre-senile or senile demen-
tia. Unlike arteriosclerotic dementia, the current formula-
tion of VaD has transformed as a distinct condition over the 
past 25 years. VaD or cerebrovascular dementia implies a 
clinically diagnosed dementia syndrome comprising sub-
types with both ischemic and haemorrhagic aetiologies 
[142]. As AD became more commonly recognised, VaD 
was often similarly characterised as a primary memory-
associated dementia but involving vascular causes.
Otto Binswanger could probably be acknowledged to 
have conveyed the notion of the existence of subclasses 
of VaD. He described subcortical arteriosclerotic encepha-
lopathy or a type of SVD-related dementia [18]. This was 
described after pathological verification of cerebral WM 
disorder in a group of patients with hypertensive disease. 
Further descriptions of distinct pathological changes in cer-
ebral vessels were another step forward towards classifica-
tion of subtypes. In 1937, W Schultz had described drusige 
entrartung or congophilic amyloid angiopathy in some 
patients. More recently, C. Miller Fisher recognised for his 
profound proposal indicated that cerebrovascular demen-
tia is a matter of both large and small strokes and provided 
clear accounts of lacunar syndromes [56]. Multiple small 
infarcts in association with hypertension (état lacunaire) 
are the commonest pathological changes linked to VaD. It 
is characterised by abrupt episodes, which lead to weak-
ness, slowness, dysarthria, dysphagia, small-stepped gait, 
brisk reflexes and extensor plantar responses. All these 
signs are largely present by the time mental deteriora-
tion occurs [73]. The recognition of subtypes of clinical 
VaD was clearly an important step towards current patho-
logical classifications based on vascular aetiology. It was 
subsequently recognised that multi-infarct dementia pre-
dominantly results from cortical infarcts attributed to large 
vessel disease, whereas dementia associated with subcor-
tical ischemic lesions or Binswanger’s disease involving 
subcortical structures and the WM results from changes in 
intracranial small vessels (Table 1).
The continuum of VCI and vascular cognitive 
disorder
VCI came into existence to empower a single label for all 
conditions in any cognitive domain that has a vascular ori-
gin or impaired brain perfusion [118]. While useful, it is 
challenging to consistently correlate the degree of patho-
logical changes with the degree of impaired cognition in 
the continuum of VCI [65, 72, 118]. The description vascu-
lar cognitive disorder [145] also incorporates a continuum 
comprising cognitive disorders of vascular aetiology with 
diverse pathologies and clinical manifestations. Therefore, 
in the most recent diagnostic and statistical manual of men-
tal disorders (DSM) or DSM-V criteria and guidelines, the 
categories of mild and major vascular cognitive disorders 
were introduced [8]. Vascular cognitive disorder indicated 
a global diagnostic category, restricting the term VCI to 
patients whose cognitive impairment fell short of demen-
tia [142]. The major neurocognitive disorder classifica-
tion, meant to describe frank dementia as a substitute for 
VaD, appears to fit better with patients and more adapted to 
neurodegenerative cognitive disorders for which memory 
impairment is not predominant, but comprises substantial 
frontal lobe pathology [146].
Cognitive impairment or dementia following stroke is 
recognised to be relatively common [102, 129]. Incident 
dementia after stroke or post-stroke dementia (PSD) has 
become better defined in recent years. PSD may develop 
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within 3 months or after a stabilisation period of a year or 
longer after stroke injury [4, 16, 133]. However, PSD can 
have a complex aetiology with varying combinations of 
large and SVD as well as non-vascular pathology. Stroke 
injury or CVD may unmask other preexisting disease pro-
cesses such as AD. It has been recently demonstrated that 
at least 75 % of PSD cases fulfilling relevant clinical guide-
lines for VCI are pathologically confirmed as VaD with lit-
tle or no AD pathology [4]. Thus, most of PSD is VaD.
Clinical information on vascular causes 
of dementia
Review of the medical records of a patient who has died 
with CVD provides insight into the nature of clinical pro-
gression and identifies anatomical regions linked to any 
patterns of changes in cognition or behaviour. It also assists 
in planning extra histological sampling in addition to the 
standard brain cutting and sampling procedures (Table 2). 
Table 2  Pathological lesions 
in CVD for neuropathology 
reporting
CAA cerebral amyloid angiopathy, CVD cerebrovascular disease, NFT neurofibrillary tangles, WM white 
matter, WMD white matter disease
a Gross examination The protocol for examination of brains from CVD subjects is essentially similar to 
that for any other disease. The routine includes looking for sites and volumes of haemorrhages, herniation, 
malformations, swelling or oedema and atrophy. Any extradural, subdural or subarachnoid haemorrhage(s) 
that has occurred should be noted. There may be signs of ruptured aneurysms, cortical lacerations, burst 
intracranial haemorrhage and leakage of intraventricular haemorrhage through the cerebellar foramina. The 
basal cerebral arteries and vertebro-basilar arteries and the main branches can be checked for the degrees of 
atheroma and the presence of thrombosis. Open branch points, for example, at the trifurcation of the inter-
nal carotid and middle cerebral artery are common sites for emboli. Vascular abnormalities may include 
aneurysms, clips and endovascular coils and malformations. The leptomeninges should be assessed for 
thickness and translucency, which may be altered much with age
b For reporting purposes, each of the above features can be scored numerically to provide a summary [72]. 
For example, 0 is absent and 1 means present. Less frequent lesions including watershed infarcts and lami-
nar necrosis. Increasing numerical value may also be assigned to the infarcts
Key variables for pathological diagnosis
 Ischaemic or haemorrhagic infarct(s)
 Is the haemorrhagic lesion(s) a major component?
Gross pathological featuresa
 Atherosclerosis (basal, peripheral or meningeal), large infarcts, haemorrhage, herniation, malformations, 
atrophy
Microscopic vascular changesb
 Microvascular disease (sporadic, hyertensive)
 Microvascular disease (e.g. CAA)
 Other microangiopathies
 Small vessel disease changes: lipohyalinosis; fibroid necrosis, hyalinisation, collagenosis
 Perivascular dilatation
Parenchymal changesb
 Location: cortex, WM, basal ganglia, brainstem (pontine), cerebellum
 Circulation involved: arterial territories—anterior, middle or posterior
 Laterality: right or left anterior and posterior
 Sizes/number of infarcts = dimension: 0–4, 5–15, 16–30, 31 > 50 mm
 Microinfarction; <5 mm determined as small or microinfarcts
 Lacunes and lacunar infarcts: etat lacunaire and etat crible (grey and WM)
 Leukoencephalopathy (WMD): anterior vs. posterior; periventricular vs deep WM
  Rarefaction/incomplete or subinfarctive ischemic injury
 Degree of perivascular and parenchymal gliosis: mild, moderate or severe
 Hippocampal sclerosis: mild, moderate and severe
 Alzheimer pathology (NFT, neuritic plaque staging). >stage III = mixed AD and VaD
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Strategies for the staged examination of the postmortem 
brain in suspected dementia have evolved over time with 
the increasing use of immunohistochemical and molecular 
tools for diagnosis. This has led to an expanding range of 
diagnostic categories (Table 1). In CVD cases, diagnostic 
imaging may have been performed that will also be use-
ful for the diagnosis. However, clinical information plays 
an important role in the formulation of a clinicopathologi-
cal summary. Thus, a number of questions should be con-
sidered: (1) How was the diagnosis of dementia made? (2) 
Was the assessment been made by a clinician experienced 
in dementia? (3) Have causes of secondary dementia been 
excluded? (4) Has there been longitudinal assessment of 
the patient with application of bedside tests of cognitive 
function? It is common for a diagnosis of dementia to be 
applied to an elderly subject who has delirium or is cogni-
tively impaired because of an acute problem and is there-
fore best classed as having an acute confusional state? 
Depression may also lead to poor global performance and 
is a recognised cause of pseudo-dementia. Another ques-
tion relates to the domains of cognition affected first. At 
the end stage of disease, it can be clinically difficult to 
discriminate between different diseases. The early clinical 
features obtained from medical records often give impor-
tant clues to the subsequent pathological diagnosis for 
which the pathologist attempts to distinguish between the 
various clinico-anatomic syndromes [88]. Further specific 
questions concern neurological features associated with the 
decline in cognitive function that can be attributed to the 
cause of dementia.
Neuropsychometric correlates of VCI and VaD
Upon evaluation of clinical information including history, 
timing of event, neuropsychometry and neuroimaging of 
the DSM criteria are mostly widely applied to define the 
presence of dementia. In the DSM-IV and earlier versions 
of DSM criteria, diagnosis of dementia placed emphasis 
on memory loss as a core feature. However, many patients 
with VaD will not necessarily have profound memory defi-
cits, particularly in the early stages. They predominantly 
develop a frontal dysexecutive syndrome [40]. This short-
fall has been overcome in recently proposed guidelines for 
the diagnosis of minor and major vascular cognitive disor-
der, which concentrates on speed of information process-
ing, complex attention and frontal-executive functioning 
[146]. Another advancement in this context is the use of 
the Montreal Cognitive Assessment (MoCA) as a preferred 
first cognitive screening instrument to challenge the well-
established Mini-Mental State Exam (MMSE). Both the 
full and short versions of the MoCA appear to have excel-
lent diagnostic accuracy in discriminating VaD patients in 
terms of sensitivity and specificity against the MMSE [58]. 
To define various cognitive domains for assessment of 
executive dysfunction including features such as processing 
speed, attention and reaction time, different centres use var-
iations of established neuropsychometric batteries and tests 
such as the Automated Geriatric Examination for Com-
puter-Assisted Taxonomy (AGECAT), Cambridge Cogni-
tive Examination (CAMCOG), Cambridge Examination for 
Mental Disorders (CAMDEX), Cognitive Abilities Screen-
ing Instrument (CASI) and Mattis Dementia Rating Scale 
(MDRS), which are most often biased for AD (Table 3).
Towards the diagnostic criteria for VaD
In the past, several proposals were made to better define 
the diagnostic criteria for VaD [182, 183]. These have vari-
able specificities and sensitivities and are not interchange-
able with substantial misclassification of dementias [35, 62, 
135]. The inclusion of deficits in certain cognitive domains 
such as memory, which is primary to AD, concurs with the 
relatively low sensitivity (0.20), but high specificity (0.93) 
for probable VaD apparent in clinicopathological valida-
tion studies [62]. In earlier studies, the Hachinski Ischae-
mic Scale used was used to indicate the presence of multi-
infarct dementia in demented patients who scored ≥7 out of 
10. Subsequent specific developments included the Alzhei-
mer’s Disease Diagnostic and Treatment Centers (ADDTC) 
criteria for ischaemic VaD [33], the National Institute for 
Neurological Disorders and Stroke-Association Interna-
tionale pour la Recherché et l’Enseignement en Neuro-
sciences (NINDS-AIREN) criteria for VaD [144] and the 
International Classification of Diseases (ICD-10) criteria 
for VaD. The ADDTC followed by the NINDS-AIREN cri-
teria for possible (ischaemic) VaD achieves the best balance 
of sensitivity and specificity with reasonable agreement 
with DSM-IV criteria for possible VaD. However, none 
of the criteria including the ADDTC, NINDS-AIREN and 
ICD-10 consistently revealed high sensitivity for probable 
VaD. Despite the deficiencies, the NINDS-AIREN criteria 
are still most widely used, particularly in research settings. 
The NINDS-AIREN criteria emphasise the heterogeneity 
of VaD syndromes and pathological subtypes (e.g. ischae-
mic and haemorrhagic strokes, cerebral hypoxic–ischaemic 
events, WM changes) [144]. The three cardinal features of 
VaD that harmonise with NINDS-AIREN criteria for the 
clinical diagnosis of probable VaD include (1) acute onset 
of dementia, demonstrated by impairment of memory and 
two other cognitive domains, such as orientation, praxis, or 
executive dysfunction, (2) relevant neuroimaging evidence 
of cerebrovascular lesions and (3) evidence for a temporal 
relation between stroke and cognitive loss [142]. Although 
neuroimaging evidence of vascular lesions is required for a 
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diagnosis of probable VaD, the NINDS-AIREN criteria do 
not distinguish between subjects with and without demen-
tia in the context of CVD [11]. The diagnosis of ‘definite’ 
VaD requires histopathological evidence of CVD (Table 2), 
an absence of neurofibrillary tangles and neuritic plaques 
exceeding those expected for age and an absence of other 
conditions associated with dementia [90].
Despite the wide use of NINDS-AIREN and DSM-IV 
criteria, postmortem examination is not performed in gen-
eral. However, when they do occur, inaccuracy of clinically 
diagnosed VaD is often revealed. Invariably, autopsy find-
ings reveal subjects with AD type of pathological changes 
[45, 80, 87]. For example, a US study [117] reported that 
87 % of the patients enrolled in a prospective series to 
examine VaD in a dementia clinic setting were found to 
have AD either alone (58 %) or in combination with CVD 
(42 %). All of the patients with signs of CVD were also 
found to have some concomitant neurodegenerative dis-
ease. Similarly, another study indicated that large numbers 
of ‘pure’ VaD cases without co-existing neuropathologi-
cal evidence of AD are uncommon [80]. This means that 
the current clinical diagnostic criteria are useful to detect 
pathology, but not necessarily “pure” pathology [79, 95]. 
There are currently no widely validated criteria for either 
VCI or vascular cognitive disorder [63, 72, 146]. Unbiased 
criteria encompassing relevant cognitive domains for VCI 
still need to be widely evaluated [39, 65, 72]. However, as 
with AD, definitive diagnosis of VaD is made at autopsy, 
but appropriate sampling and essential neuropathologi-
cal examination are necessary to rule out significant other 
pathological changes associated with different causes of 
cognitive impairment [72].
Several factors account for the difficulty in deriving an 
accurate diagnosis of VaD. These include sampling bias, 
inadequate sample size and absence of pathological verifi-
cation in many clinical studies; the use of non-standard or 
difficult-to-compare assessment instruments for clinical, 
neuropsychological, neuroimaging and neuropathologi-
cal evaluation [72, 127]; and, equally important, disagree-
ment over interpretation of data. More sensitive neuroim-
aging modalities have increased antemortem recognition of 
vascular changes in dementia patients, but these have also 
become harder to interpret, by revealing similar lesions in 
non-demented individuals. As discussed above, accurate 
diagnosis is also not straightforward given the heterogene-
ity of vascular lesions and the inherent issues with stand-
ardisation, especially when assessing mixed pathologies 
[63]. Depending on the inclinations of the observer, cases 
of AD with coexistent vascular lesions such as infarcts may 
be classified variously as VaD, or AD with coexistent vas-
cular pathology, or mixed dementia [55, 149]. To derive 
more accurate prevalence or incidence estimates and patho-
logical diagnosis, uniformity in protocols and appropriate Es
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brain sampling at autopsy across different centres are nec-
essary [3, 39, 63, 72, 127, 158].
Clinicopathological correlation in VaD: past and 
present
Although diagnostic criteria for the neuropathological vali-
dation of VaD are lacking, neuroimaging and clinicopatho-
logical studies have clearly indicated that the threshold for 
VaD depends on the extent of cerebral damage. A combina-
tion of factors including origin, volume, location and num-
ber of lesions contribute to the development of dementia. 
Tomlinson and colleagues had previously determined that 
the total volume of infarcts in demented stroke patients was 
usually over 50 mL and in some cases greater than 100 mL, 
exceeding that in non-demented stroke patients [19, 165]. 
Subsequent clinicopathological studies reported that only 
5 of 23 patients with a pathological diagnosis of VaD had 
more than 50 mL of infarcted tissue and 7 had less than 
10 mL [45]. It is now clear that widespread small ischae-
mic lesions or multiple microinfarcts [178, 179] distributed 
throughout the CNS correlate better with dementia and 
are key predictors of cognitive impairment [86]. Location 
of lesions may also be more critical than total volume [41, 
46]. For example, infarction in the left hemisphere dispro-
portionately increases the risk of dementia [41, 64, 104, 
134]. Bilateral infarcts with greater involvement of the 
dominant hemisphere also increase the risk of dementia 
after stroke [38, 45, 104].
Relatively few prospective studies have validated crite-
ria for VaD. Previous criteria for Binswanger’s disease or 
cerebral SVD [17] proposed that the clinical diagnosis of 
dementia accompanied by neuroimaging evidence (CT or 
MRI) of bilateral abnormalities and at least two of three 
findings included evidence of (1) a vascular risk factor or 
systemic vascular disease, (2) focal cerebrovascular disease 
and (3) “subcortical” cerebral dysfunction described by 
gait disorder, parkinsonism, or incontinence. These criteria 
were validated in a prospective series of 184 patients with 
AD and showed that only 1.6 % were diagnostically mis-
classified when all three clinical criteria were met [17].
The Oxford Project to Investigate Memory and Ageing 
(OPTIMA) study has recently developed a simple, novel, 
image-matching scoring system [155] to relate the extent 
of SVD with cognitive function in a study of 70 cases with 
insufficient pathology to meet the criteria for the diagno-
sis of AD. The severity of SVD pathology was inversely 
related to cognitive scores and 43 % of the cases with high 
SVD scores were designated as being demented. To bet-
ter define clinicopathological correlation in subtypes of 
VaD including SVD, a staging system related to the natu-
ral history of cerebrovascular pathology and an algorithm 
for the neuropathological quantification of the CVD burden 
in dementia have been proposed [39]. The staging system 
(I–VI) needs further evaluation against cognitive func-
tion scores to determine whether this system can be used 
in large-scale studies to understand the clinicopathological 
correlations.
Neuropathological diagnosis of VaD should be based 
on the absence of a primary neurodegenerative disease 
known to cause dementia and the presence of cerebrovas-
cular pathology that defines one or more of the VaD sub-
types (Table 1). These would also include dementia among 
post-stroke survivors who fulfill the NINDS-AIREN cri-
teria [144] for probable VaD. Stroke survivors with mild 
cognitive impairment or VCI [118] may also have suf-
ficient pathology for neuropathological diagnosis of VaD 
[4]. A proposal for the neuropathological diagnostic evalu-
ation of VaD was previously published by the Newcastle 
investigators (Fig. 1). According to these criteria, there are 
two neuropathological diagnostic groups: probable VaD 
is based on the exclusion of a primary neurodegenera-
tive disease known to cause dementia plus the presence of 
cerebrovascular pathology that defines one or more of the 
VaD subtypes. Possible VaD is designated when the brain 
contains vascular pathology that does not fulfill the criteria 
for one of the subtypes, but where no other explanation for 
dementia is found. Post-stroke survivors are often classed 
as subtypes I–III. Cases with extensive WM disease in the 
absence of other significant pathologies are included under 
SVD.
Assessing the neuropathological substrates of VaD 
involves systematic assessment of parenchymal lesions, 
including microinfarcts and haemorrhages and the vascu-
lar abnormalities that may have caused them to relate to 
the progression of impairment [39, 90, 110, 155, 158]. In 
addition, systemic factors (e.g. hypotension, hypoglycae-
mia) may cause brain or neuronal lesions in the absence of 
severe vascular disease and should be taken into account 
when attributing causes to VaD. As discussed above, paren-
chymal abnormalities of neurodegenerative type may be 
present that are not obviously associated with either vascu-
lar disease or systemic factors, i.e. Alzheimer type or hip-
pocampal lesions.
Frequency of pathologically diagnosed VaD
Confirmation of VaD diagnosis is definitive at autopsy 
derived from appropriate sampling of both cerebral hemi-
spheres and neuropathological examination [72] to rule 
out significant pathological changes associated with other 
dementias. The prevalence of early-onset dementia VaD 
(<65 years old) ranges from 3.1 to 44 % in various clinic 
and population-based studies across the world [172]. 
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However, these values may not reflect the true prevalence 
and incidence rates of VaD due to inconsistencies in diag-
nostic criteria, sampling methods and subject or coun-
try demographics and variation in morbidity and mortal-
ity trends. When a range of clinical criteria was applied 
to sample sizes of 59–1929, autopsy studies showed that 
pathologically diagnosed VaD ranges widely from as low 
as 0.03 % to as high as 58 % with an overall mean esti-
mate of 17 % [84]. In Western countries, the estimated 
rates of pathologically diagnosed VaD as defined by vari-
ous criteria lie between 8 and 15 %. In studies where diag-
nosis was restricted to the currently used NINDS-AIREN 
criteria [144], the frequencies are reported to be ~7 %. 
Taking the above estimates into consideration, the world-
wide frequency of VaD in autopsy-verified cases is calcu-
lated to 10–15 %, being marginally less than when clini-
cal criteria alone are used [13, 95]. In Japan, the incidence 
of autopsy-verified VaD was previously 35 % [150] and 
later reported to be 22 % [1]. Population-based cohorts 
should provide the best estimates for pathology-verified 
VaD. However, there are only few such studies and they all 
show that microvascular lesions occur more frequently than 
neurodegenerative lesions in elderly community-dwelling 
subjects with dementia [29, 148, 157, 181].
Sampling and investigation of the brain
Some form of CVD is common among the assortment of 
all routine autopsies. Stroke is the most frequent CVD 
disorder with more than 200 causes. Stroke-related injury 
may comprise microscopic lesions such as microinfarcts 
and microhaemorrhages to large cortical infarcts and lobar 
haemorrhages (Table 1). Recent advances in neuroimaging 
and systematic neuropathological examination have ena-
bled better definitions of clinically diagnosed CVD, which 
causes cognitive impairment [72]. The pathological diagno-
sis of VaD or VCI, however, requires the systematic evalu-
ation of potentially relevant clinical or phenotypic features 
with particular attention to the timing of events [88]. It is 
difficult to define which neuropathological changes and to 
what degree these contribute to dementia because of the 
heterogeneous localisation of lesions and the co-existence 
of other pathologies including neurodegenerative changes 
Fig. 1  Schematic diagram of different cerebrovascular pathologies 
associated with dementia. The proposed Newcastle categorisation 
includes six subtypes [90]. In all the above, the age of the vascular 
lesion(s) should correspond with the time when the disease began. 
The post-stroke survivors are usually included in subtypes I–III. 
While these may not be different from other published subtypes [84], 
they are practical and simple to use. Cases with extensive WM dis-
ease in the absence of significant other features are included under 
SVD. *Subtype I may result from large vessel occlusion (athero-
thromboembolism), artery to artery embolism or cardioembolism. 
Subtype II usually involves descriptions of arteriosclerosis, lipohya-
linosis and hypertensive, arteriosclerotic, amyloid or collagen angi-
opathy. Subtypes I, II and V may result from aneurysms, arterial dis-
sections, arteriovenous malformations and various forms of arteritis 
(vasculitis). AD Alzheimer’s disease, CH cerebral haemorrhage, CVD 
cerebrovascular disease, MI myocardial infarction, MID multi-infarct 
dementia, LVD large vessel disease, SIVD subcortical ischaemic vas-
cular dementia, SVD small vessel disease, VCI vascular cognitive 
impairment, VaD vascular dementia
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such as those in AD. More than one factor may contribute 
to the overall impairment and the VaD phenotype (Table 1). 
These include the origin and type of vascular occlusion, 
presence of haemorrhage, distribution of arterial territories 
and the size of vessels involved. Thus, many brain regions 
including the territories of the anterior, posterior and mid-
dle cerebral arteries, the angular gyrus, caudate and medial 
thalamus in the dominant hemisphere, the amygdala and 
hippocampus, as well as the hippocampus have been impli-
cated in VaD. Factors that define pathology in subtypes of 
VaD include multiplicity, size, anatomical location, later-
ality and age of the lesions besides genetic influences and 
previous existence of systemic vascular disease. Subcorti-
cal ischaemic VaD is likely the most significant subtype of 
VaD [142] and smaller subcortical lesions seem to be key 
players (Table 2).
Gross external examination of the brain at autopsy is 
extremely useful for a quick indication of the presence of 
cerebrovascular pathology (Table 2). As is widely prac-
ticed, the brain from CVD cases is cut in the coronal plane 
throughout. This is irrespective of whether fresh samples 
are dissected for freezing at autopsy or the brain is immer-
sion fixed for later sectioning. In Newcastle, brains from 
CVD cases are sliced fresh in the coronal plane and then 
alternate sections from each hemisphere are retained as 
fixed or frozen material, which is deposited in the New-
castle Brain Tissue Resource. While unconventional, it has 
been the normal practice for the past 30 years in Newcastle 
to sample large sections (average size 6 × 5 cm) for bet-
ter appreciation of pathology, but this is not necessarily the 
case in many laboratories (Fig. 2).
What is the best strategy for brain sampling? Various 
recommendations for brain region sampling and histo-
logical evaluation in a stratified fashion have been made 
(Table 2). Block sampling is recommended from the mid-
dle frontal gyrus, superior and middle temporal gyri, infe-
rior parietal lobule and occipital cortex; in addition, the 
medulla, pons (including locus coeruleus), cerebellar cor-
tex (including dentate nucleus), thalamus and subthalamic 
nucleus, basal ganglia at the level of the anterior commis-
sure, hippocampus and entorhinal cortex, anterior cingulate 
gyrus and amygdala [81, 111] may also be considered. The 
BrainNet Europe Consortium has previously recommended 
a sampling strategy that may be adapted for instances 
when consent is not available to retain the whole brain for 
diagnostic evaluation [2]. While these are biased towards 
neurofibrillary pathology and involve sections from the 
occipital cortex, superior and middle temporal gyrus, 
anterior hippocampus and/or amygdala and posterior hip-
pocampus at the level of the lateral geniculate body, they 
are not ideal or sufficient for scoring vascular pathology. 
The minimal sample set for scoring vascular pathology 
would include sections of the frontal lobe at the level of the 
olfactory bulbs, the temporal lobe at the level of the ante-
rior hippocampus and the basal ganglia (lenticular nucleus 
and anterior thalamus) at the level of the mamillary body 
[39]. The posterior hippocampus is included if available. 
These regions represent relevant cerebral systems involved 
in cognition and receive blood from each major cerebral 
arterial supply [39]. The National Institute on Aging-Alz-
heimer’s Association (NIA-AA) recommends the assess-
ment of hippocampal sclerosis, vascular brain injury and 
microvascular lesions in 12 regions [81]. However, as cor-
rectly recommended by the BrainNet Consortium [3], a 
simple strategy regarding assessment of load of alteration 
is urgently needed to yield reproducible and, at the same 
time, comparable results between centres.
At most centres, the histological evaluation of vascular 
pathology or brain tissue injury is undertaken in a rather 
subjective manner and is remarkably variable (Table 3). 
Degrees of vessel, e.g. arteriosclerosis and tissue changes 
(vascular brain injury) in terms of infarcts and rarefac-
tion, often reported as a composite semi-quantitative score, 
are noted to validate the clinical picture. This is probably 
adequate for routine neuropathology reporting taking into 
account the nature and extent of specific changes in the 
vascular anatomy and the parenchyma (Table 2). More rig-
orous and objective analysis is time consuming and tedious 
Fig. 2  Sampling of postmortem brain tissue for assessing vascular 
pathology. Coronal blocks from one hemisphere (rostral to caudal) of 
the cerebrum for an ‘ideal’ sample for neuropathological assessment. 
In Newcastle, large sections are taken as indicated by the pink and 
green blocks identified by the letters. A minimum sample constituting 
four to six large blocks including S, Y/W, F/J, G/H, AB/AD and AL 
can be reliably used to determine the burden of vascular pathology 
[39]
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and is more suitable for research purposes. However, vari-
ous methods for more accurate determination have been 
used to quantify the vascular pathology. Table 4 provides 
the details of various methods which can be implemented 
for quantification of vascular and relevant cellular changes.
Cerebrovascular pathology and brain 
parenchymal changes
Atherosclerotic and embolic disease are the main causes of 
infarctions associated with major arterial territories, which 
may be admixed in the cortical and subcortical regions 
[70] (Table 1). Thromboembolic events are responsible for 
up to 50 % of all ischaemic strokes, whereas intracranial 
SVD causes 25 % of the infarcts. Small vessel alternations 
involve arteriolosclerosis and hyalinosis and associated 
with lacunar infarcts predominantly occurring in the WM, 
basal ganglia and thalamus. WM disease or subcortical 
leukoencephalopathy with incomplete infarction is a com-
mon pathological change associated with dementia [39]. 
Other features include border zone (watershed) infarctions, 
laminar necrosis and cerebral amyloid angiopathy (CAA). 
Complicated angiopathies such as fibromuscular dysplasia, 
arterial dissections, granulomatous angiitis, collagen vascu-
lar disease and giant cell arteritis are rarer causes of CVD 
and VaD (Table 1).
Few studies have recorded precise ischaemic, oedema-
tous and haemorrhagic lesions induced by pathological 
changes in the brain circulation or perfusion to be associ-
ated with VaD (Table 2). In ten different studies where 
VaD was diagnosed, clinically, 78 % of the cases revealed 
cortical and subcortical infarcts suggesting that other vas-
cular pathologies involving incomplete infarction or bor-
der zone infarcts could be important factors. Among other 
lesions 25 % of the cases had cystic infarcts whereas 50 % 
showed lacunar infarcts or microinfarcts. Lacunar infarcts, 
however, appear to be a common category of infarcts and 
currently recognised as the most frequent cause of stroke 
(Table 2). Severe CAA was present in 10 % of the cases. 
Hippocampal sclerosis and cell atrophy, which may be 
caused by remote ischaemic injury, was apparent in 55 % 
of the cases in one study with clinical diagnosis of ischae-
mic VaD [173]. In an attempt to evaluate the natural his-
tory and staging of CVD, Deramecourt et al. [39] proposed 
that vessel wall modifications such as arteriolosclerosis or 
CAA were the most common and earliest changes. These 
were followed by perivascular spacing with lacunar and 
regional microinfarcts infarcts occurring as consequent, 
but independent processes. The regional progression of the 
changes were frontal > temporal lobe ≥ basal ganglia. In 
dementia subjects, VaD had the highest total scores of vas-
cular pathology, whereas AD was the second and dementia 
with Lewy bodies was the last but greater than in ageing 
controls [39].
Interaction between vascular and Alzheimer type 
of pathologies
Concurrent CVD is a common neuropathological finding 
in aged subjects with dementia and more common in AD 
than in other neurodegenerative disorders, especially in 
younger subjects. This is evident not only in samples from 
memory clinics we first evaluated over 20 years ago [136], 
but also in those from large multicentre studies [164]. In 
the National Alzheimer’s Coordinating Centre minimum 
data set sample of 4429 clinically diagnosed AD cases, the 
presence of CVD and any vascular pathology was reported 
to be 32 and 80 % respectively. Approximately, 20 % of 
these had lacunes and microinfarcts [164]. The admixture 
of CVD pathology and neurodegenerative changes particu-
larly neurofibrillary and α-synuclein pathologies is even 
greater in elderly people within the community at large [29, 
140, 157]. The co-occurrence of CVD lowers the threshold 
for dementia caused by a single neurodegenerative process. 
In one community-based sample, 38 % of dementia cases 
had mixed pathology, with both Alzheimer-type changes 
and vascular lesions, but ‘pure AD’ represented only 
21–24 % of the cases [148]. WM lesions indicating ischae-
mic or oligaemic aetiology are also high in community-
dwelling subjects by as much as 94 %, and this change is an 
independent substrate for dementia [50]. In addition, ather-
osclerosis in cerebral arteries and the circle of Willis [141, 
187] is frequently present in AD. The commonest overlap-
ping pathologies involve smaller cerebrovascular lesions 
rather than large infarcts [39] (Fig. 3). These include most 
features of SVD such as cortical infarcts, lacunes, diffuse 
and periventricular myelin loss, WM microvacuolation, 
microinfarcts, microhaemorrhages, arteriolosclerosis and 
focal and diffuse gliosis [10, 48, 173]. AD pathology was 
found to be three times greater in VaD cases with small 
(<15 mL) compared to large infarcts [10]. The findings also 
corroborate the importance of microvascular disease rather 
than large vessel disease as the critical substrate in VaD and 
AD.
Clinicopathological studies also suggest that vascular 
disease not only influences the burden of the neurodegener-
ative lesion [140, 190]. The density of neocortical plaques 
was lower in AD cases with coexistent vascular lesions 
interpreted as contributing to dementia [113]. In the Reli-
gious Order study, elderly nuns who exhibited coexistent 
AD and brain infarcts at autopsy had poorer cognitive func-
tion and a higher prevalence of dementia than those without 
vascular change [156]. Compared with pure AD, the lower 
burden of Alzheimer-type pathology, particularly fewer 
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neurofibrillary tangles, was required to reach the threshold 
for dementia when there were concomitant lacunar infarcts 
in subcortical structures including the basal ganglia, thal-
amus or deep WM. Similarly, in another religious order 
study, after accounting for AD lesion burden, the pres-
ence of other pathologies or infarcts increased the odds of 
dementia over fivefold [148] and caused earlier onset of 
dementia [47].
Pathology of extra‑ and intracranial large vessels
Large infarction or macroinfarction should be visible upon 
gross examination of the brain at autopsy. Stenosis aris-
ing from atherosclerosis within large vessels is considered 
the main cause of large infarction, which may sometimes 
extend beyond the arterial territories. The stages of athero-
sclerosis may vary from accumulation of foam cells causing 
fatty streaks to complicated atheromas involving extracel-
lular matrix components and even viral or bacterial infec-
tions [88]. Approximately, 15 % of VaD assumes occlu-
sion of the extracranial arteries such as the internal carotid 
artery and the main intracranial arteries of the circle of 
Willis including the middle cerebral artery, leading to mul-
tiple infarcts and dementia [24]. The differences between 
the anterior versus posterior portions of the circle of Willis 
and left versus right sides may be variable, and stenosis of 
major arteries could be up to 75 % in very severe cases. 
Typical atherosclerosis or microatheromatous disease in the 
meningeal and smaller vessels, beyond the circle of Willis 
involving the proximal segments of the middle and ante-
rior cerebral arteries, is generally rare, but may be found in 
very old subjects [91]. The presence of dolichoectasia and 
fusiform aneurysms has also been noted in some cases. In 
severe cases, medium-sized arteries in the leptomeninges 
and proximal perforating arteries are involved. The damage 
could be worse depending on the presence of hypertension.
Arterial territorial infarctions involve four principal 
areas, particularly those supplied by the major arteries: 
anterior, middle cerebral artery, posterior artery and the ter-
ritory between the anterior and middle cerebral artery. The 
intensity of gliosis, both astrocytic and microgliosis, is an 
important consideration in judging the degree and age of 
infarction. However, there is no clear evidence to suggest 
these are related to cognitive impairment. Degrees of gli-
osis or glial scars are noted in brains subjected to global 
ischaemia, i.e. after transient cardiac arrest where responses 
may be observed in vulnerable neuronal groups within the 
hippocampus or neocortical laminae.
Small cerebral vessels
SVD entails fibroid necrosis, hyalinisation of vessels, 
expansion of the perivascular space and pallor of adja-
cent perivascular myelin, with associated astrocytic gliosis 
(Fig. 4). The smaller vessels of the brain including intrac-
erebral end arteries and arterioles undergo progressive 
age-related changes [99], which alter perfusion and cause 
lacunar infarcts (cystic lesions generally <1 cm) and micro-
infarcts. The arteriolar changes range from wall thicken-
ing by hyalinosis, reduction or increment of the intima to 
severe arteriolosclerosis and fibroid necrosis. Arterioloscle-
rotic changes likely promote loss of elasticity to dilate and 
constrict in response to variations of systemic blood pres-
sure or auto-regulation, which in turn causes fluctuations 
in blood flow response and changes in tissue perfusion. 
The deep cerebral structures and WM would be rendered 
most vulnerable, because the vessels are end arteries almost 
devoid of anastomoses. Small vessel pathology could also 
lead to oedema and damage of the blood–brain barrier 
(BBB) with chronic leakage of fluid and macromolecules in 
the WM [61, 78, 175]. Microvascular disease may also be 
associated with degrees of inflammation including the pres-
ence of lymphocytes or macrophages localised on blood 
vessels (and not necessarily a function of brain ischaemia). 
In the oldest SVD subjects, there may also often be evi-
dence of remote haemorrhage in the form of perivascular 
hemosiderin [39].
Lacunar infarction
Lacunar infarcts, about 1 cm or less in diameter, may occur 
as complete or cavitating lesions frequently in both sub-
cortical grey and WM in VaD. They represent small foci of 
ischaemic necrosis resulting from narrowing or occlusion 
of penetrating arteries branching directly from larger cer-
ebral arteries [56]. Lacunar infarcts are frequently multiple 
and bilateral and often coexist with other vascular lesions 
Fig. 3  Pathological outcomes of clinically diagnosed VaD. Mixed 
type 1 revealed large infracts, whereas mixed type 2 predominantly 
exhibited SVD with microinfarction. Other included Lewy body dis-
ease, dementia, mild Parkinson disease and depression. AD Alzhei-
mer’s disease
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(e.g. large infarcts or diffuse WM damage). Whether sin-
gle or multiple, they may be asymptomatic, depending on 
their location and the volume of normal brain tissue lost. 
Lacunes may also represent small haemorrhages or dilated 
perivascular spaces without infarction or haemorrhage. A 
few lacunes may represent healed or re-absorbed as minute 
or petechial haemorrhages. Microlacunes have also been 
described which essentially should be thought of as large 
cystic microinfarcts.
Apart from critical lesions occurring often in the internal 
capsule or caudate nucleus, recent meta-analyses suggested 
there were no pathological differences between sympto-
matic and asymptomatic patients. Perivascular oedema and 
thickening, and inflammation and disintegration of the arte-
riolar wall were common, whereas vessel occlusion was 
rare [9], In neuropathological studies of elderly patients 
with vascular disease but without evidence of AD or other 
neurodegenerative pathologies, dementia was associated 
with severe cribriform change and associated subcortical 
WM damage and microinfarcts [48, 158]. In the Hono-
lulu–Asia Aging Study (HAAS) analysis [179], microvas-
cular infarcts (lacunar and microinfarcts) were identified 
as the sole or dominant lesion in 34 % of the definitely 
impaired decedents. Only leukoencephalopathy was associ-
ated with dementia, and large infarcts were associated with 
VaD. VaD without significant AD pathology shows more 
severe cribriform change and deep white and grey matter 
lacunar or microinfarcts than stroke subjects with macro-
scopic infarcts and elderly subjects without dementia [155]. 
Similarly, lacunar infarcts and microinfarcts were the most 
common neuropathological features in more than 50 % of 
elderly patients with ischaemic VaD [173] and also strong 
determinants of dementia in the Geneva brain ageing study 
[60]. However, all these findings were also often accompa-
nied by moderate to severe atherosclerosis.
Fig. 4  Pathological features associated with SVD in VaD. Panels 
show examples of lacunes, small infarcts and microinfarcts. a Typi-
cal cavitated lacunar lesions (arrow) in the putamen of a 65-year-old 
man. b WM attenuation in the medial temporal lobe, but sparing of 
U fibres. Section from an 80-year-old man with vascular and neurofi-
brillary pathology. c, d Cerebral microvessels with variable hyalino-
sis, perivascular rarefaction, microinfarcts and perivascular spaces in 
two different cases. Moderate gliosis in the surrounding region is also 
evident in the case in c. d Perivascular dilatation (or spacing) in the 
WM (arrow). Magnification bar a 1 cm, b 500 μm, c, d 100 μm
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White matter changes
White matter hyperintensities on T2-weighted MRI or leu-
koaraiosis as a decreased signal on computed tomography 
(CT) is a neuroimaging construct to describe diffuse and 
focal WM changes. Leukoariaosis predominantly has refer-
ence to vascular disease. It not only incorporates WM rar-
efaction, incomplete infarction, lacunar strokes, perivascu-
lar spacing and demyelination, but sometimes also axonal 
degeneration (Figs. 4 and 5). Both, areas of leukoaraiosis 
and zones outside the lesions show decreased vascular 
density indicating that leukoaraiosis appears as a general-
ised feature of CVD rather than being limited to the deep 
WM. This is consistent with the finding of an association of 
unstable carotid plaques with the number of WM lesions, 
suggesting a thromboembolic role in some patients with 
leukoaraiosis [5].
Neuroimaging and pathological studies demonstrate 
that WM hyperintensisties represent degeneration of the 
WM mostly explained by SVD [125, 126, 158]. Diffuse 
and focal WM lesions are a hallmark of VaD [82], but 
also occur most in ~30 % of AD and dementia with Lewy 
body (DLB) cases [44]. There is some controversy whether 
deep or periventricular lesions are of more importance, but 
this depends on the definition of boundaries between the 
periventricular and deep WM if the coursing of the fibres is 
used as markers [96]. Lacunar infarcts are produced when 
the ischaemic damage is focal and of sufficient severity 
to result in a small area of necrosis, whereas diffuse WM 
change is considered a form of rarefaction or incomplete 
infarction where there may be selective damage to some 
cellular components. Although the U fibres are frequently 
spared WM disease may comprise several patterns of alter-
ations including pallor or swelling of myelin, loss of oligo-
dendrocytes, damage to axons, cavitations with or without 
the presence of macrophages and areas of reactive astro-
gliosis [152], where the astrocytic cytoplasm and cell pro-
cesses may be visible with standard stains. Oligodendro-
cytes are particularly vulnerable to hypoxic environment 
created by low perfusion, which in turn may differentially 
affect myelin as indicated by the remarkable reduction in 
the ratio of myelin-associated glycoprotein (MAG) to pro-
teolipid protein 1 (PLP1) not only in the WM, but also the 
cerebral cortex in VaD [12, 163].
Lesions in the WM also include spongiosis, i.e. vacu-
olisation of the WM structures and widening of the 
perivascular spaces [186]. The affected regions do not 
have sharp boundaries, in contrast to the plaques of mul-
tiple sclerosis. These changes may be associated with 
chronic pro-thrombotic endothelial dysfunction in cere-
bral SVD [77] also involving the WM [23]. There may be 
a cerebral response to the SVD by increasing endothelial 
thrombomodulin [61]. The projected misery perfusion due 
to capillary loss or abnormalities occurring prior to leu-
koaraiosis corroborates the finding of a chronic hypoxic 
state in the deep WM [51], which also releases several 
growth promoting factors [153]. Some of the WM dam-
age in demented patients may simply reflect Wallerian 
changes secondary to cortical loss of neurons. However, 
histological changes characteristic of Wallerian degenera-
tion are not readily evident as WM pallor. Conversely, in 
AD patients with severe loss of cortical neurons, similar 
WM lesions are not apparent [44].
While WM changes focus on the arterial system, nar-
rowing and, in many cases, occlusion of veins and venules 
by collagenous thickening of the vessel walls also occur. 
The thickening of the walls of periventricular veins and 
venules by collagen (collagenosis) increases with age, and 
perivenous collagenosis is increased further in brains with 
leukoaraiosis [22]. The presence of apoptotic cells in WM 
Fig. 5  WM lesions visualised by conventional histopathological 
staining in a 69-year-old man diagnosed with vascular encephalopa-
thy (and VaD). a >75 % stenosis in the internal carotid artery 8 mm 
above the bifurcation. The narrowed lumen (arrow) is seen. b Severe 
WM changes in the parietal lobe in this patient. Braak staging was 
graded as IV, but there were no neuritic or cored plaques. c Post-
mortem T2W magnetic resonance image of a formalin-fixed block 
from the parietal lobe. The area of hypersignal can be seen in the 
WM (asterisk). d H&E stained section from the block in c showing 
severe deep WM pallor in the area of hypertensity (asterisk). A small 
cortical infarct is also seen (arrow). Magnification bar a 500 mm, b 
400 μm, c 1 cm, d 500 μm
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adjacent to areas of leukoaraiosis suggests that such lesions 
are dynamic, with progressive cell loss and expansion 
[22]. Vascular stenosis caused by collagenosis may induce 
chronic ischaemia or oedema in the deep WM leading to 
capillary loss and more widespread effects on the brain 
[23].
Cerebral microinfarction
The accumulation of small, even miniscule ischaemic 
lesions as an important substrate of VaD has been empha-
sised in recent years [86]. Microinfarcts are widely 
accepted to be small lesions visible only upon microscopy 
(Fig. 4; Table 3). These lesions of up to 5 mm diameter 
may or may not involve a small vessel at its centre, but are 
foci with pallor, neuronal loss, axonal damage (WM) and 
gliosis. They are estimated to occur in thousands [178]. 
Sometimes these may include regions of incomplete infarc-
tion or rarefied (subacute) change. Microinfarcts have been 
described as attenuated lesions of indistinct nature occur-
ring in both cortical and subcortical regions. Such lesions 
or a combination of these are reported when there are mul-
tiple or at least greater than three present in any region 
(Table 2). Microvascular infarcts (lacunar infarcts and 
microinfarcts) appear central to the most common cause of 
VaD (Fig. 4) and predict poor outcome in the elderly [10, 
21, 173]. Interestingly, in the autopsied older HAAS, the 
importance of microvascular lesions as a likely explanation 
for dementia was nearly equal to that of Alzheimer lesions 
[179, 180]. Microinfarction in the subcortical structures has 
been emphasised as a substrate of cognitive impairment [6, 
86] and correlated with increased Alzheimer type of pathol-
ogy, but cortical microinfarcts also appear to contribute to 
the progression of cognitive deficits in brain ageing [97].
In addition to microinfarction in the subcortical struc-
tures, it appears increasingly important that multiple corti-
cal areas of microinfarction are associated with subcortical 
VaD or SVD (Fig. 4). Thus, these lesions should be taken 
into account when defining the neuropathological crite-
ria. Cortical microinfarcts are increased in the presence of 
CAA [121] (Fig. 6). In a recent study, cortical microinfarcts 
were frequently detected in AD and associated with CAA, 
but rarely observed in subcortical VaD linked to SVD [120, 
159]. Microinfarcts in the cerebral cortex associated with 
severe CAA may be the primary pathological substrate in 
a significant proportion of VaD cases [74]. Cortical micro-
infarcts and to lesser extent periventricular demyelination 
were significantly associated with cognitive decline in indi-
viduals at high risk for dementia [63]. It is proposed the 
changes in hemodynamics, e.g. hypotension and athero-
sclerosis may play a role in the genesis of cortical water-
shed microinfarcts.
Large and small cerebral haemorrhages
Cerebral microbleeds detected by MRI are small, dot-like 
hypotense abnormalities, have been associated with extrava-
sated haemosiderin derived from erythrocytes, lipohyalinosis 
and CAA [49]. They are likely a surrogate marker of SVD 
evident on MRI along with lacunes and WM changes [168]. 
The prevalence of radiological microbleeds in VaD ranges 
35–85 %. Microbleeds are mainly thought to result from 
hypertensive vasculopathy, but the frequent co-occurrence of 
lobar microbleeds suggests that the neurodegenerative pathol-
ogy or CAA is also of importance [177]. The relevance of this 
radiological construct is increasingly recognised due to their 
relation to clinical outcome and occurrence in anti-amyloid 
vaccination trials [69]. However, the presence of multiple 
microbleeds in the context of VaD is related to worse perfor-
mance on cognitive tests, mainly in psychomotor speed and 
executive functioning. Since microbleeds are common in cog-
nitively normal older individuals, attribution of these to VaD 
should follow a careful exclusion of other causes of cognitive 
impairment and only if numerous such lesions are present.
Both radiological cerebral microbleeds and foci of hae-
mosiderin containing single crystalloids or larger perivascu-
lar aggregates are found in brains of older subjects includ-
ing those diagnosed with VaD and AD, but the radiological 
and pathological relationship between these findings has not 
been entirely clear. Recent evidence suggests that cerebral 
microbleeds detected by MR imaging are a surrogate for 
ischaemic SVD rather than exclusively haemorrhagic diath-
esis [83]. Greater putamen haemosiderin was significantly 
associated with indices of small vessel ischaemia, including 
microinfarcts, arteriolosclerosis and perivascular spacing 
and with lacunes in any brain region but not large vessel dis-
ease, or whole brain measures of neurodegenerative pathol-
ogy. Higher levels of putamen haemosiderin were correlated 
with more microbleeds upon MR imaging, but it is possi-
ble that brain iron homoeostasis and small vessel ischae-
mic change are responsible for these rather than only as a 
marker for minor episodes of cerebrovascular extravasation.
Hippocampal atrophy and sclerosis
Neuroimaging studies have shown that medial temporal 
lobe and hippocampal atrophy are associated with VaD 
[14, 54] and SVD [119, 167], albeit not to the same extent 
as in AD [26]. Pathological evidence shows that ischae-
mic VaD and SVD are also associated with hippocampal 
changes and atrophy remote to ischaemic injury [108, 188]. 
Hippocampal neurones in the Sommer’s sector are highly 
vulnerable to disturbances in the cerebral circulation or 
hypoxia caused by systemic vascular disease. The focal 
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loss of CA1 neurons in ischemic VaD has been related to 
lower hippocampal volume and memory score [188], but 
the degree of loss appears less in VaD [98] than in AD. 
However, selective hippocampal neuronal shrinkage is 
also an important substrate for VaD. This is also evident in 
delayed dementia after stroke in the absence of any neuro-
degenerative pathology [59]. Thus, there is a clear vascular 
basis for hippocampal neurodegeneration and concurs with 
the neuroimaging observations of hippocampal atrophy 
even in population-based incident VaD [147]. The simplest 
mechanistic explanation for the atrophy is that the neuronal 
or dendritic arbour results in subsequent loss in connec-
tivity, which contributes to brain structural and functional 
changes. This is consistent with the finding that soluble 
synaptophysin was decreased in VaD as well as AD.
Hippocampal sclerosis is a likely a major contributing fac-
tor in the hippocampal atrophy and occurs in approximately 
10 % of individuals over the age of 85 years and slightly 
higher in VaD. It is characterised by severe cell loss with 
the CA fields in the presence or absence of microinfarction 
Fig. 6  CAA and infarcts in a 92-year-old woman with memory loss, 
confusional state and disorientation. CT on admission showed infarc-
tion in the right posterior parieto-occipital region. Small lacunar 
infarct in the posterior aspect of the left corona radiata, probable area 
of cortical infarction in the left occipital lobe. a Lobar haemorrhage 
in the frontal lobe. b Macroscopical cortical infarcts in both right 
and left occipital lobes. c, d Cortical and subarachnoidal arterioles 
showing thickened homogenous eosinophilic walls. Inset in c, two 
strongly stained eosinophilic vessels. e Aβ immunohistochemistry 
shows extensive subarachnoidal and cortical amyloid angiopathy. f A 
cortical microinfarct with haemosiderin. There were numerous micro-
infarcts in the frontal, parietal and occipital cortices. Subject only 
showed sparse cored and diffuse senile plaques and Braak stage II for 
neurofibrillary pathology. Magnification bar a, b 1 cm, c–f 100 μm
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and gliosis that is not explained by AD. TAR DNA protein 
43 immunohistochemistry can be used to demonstrate that 
hippocampal sclerosis, regardless of accompanying patholo-
gies (e.g. AD or vascular), is consistent with an underlying 
neurodegenerative pathogenetic mechanism [189]. Any focal 
loss or patterns of hippocampal sclerosis can be graded [137] 
and recorded together with any microinfarctions. Some-
times, the patchy neuron loss and gliosis in some brains with 
AD pathology may be difficult or impossible to distinguish 
from anoxic–ischemic change. The aetiology of hippocam-
pal sclerosis is defined in association with a neurodegenera-
tive process, a pathologic condition presumed to arise from 
hypoxic/ischemic mechanisms [137]. Hippocampal scle-
rosis pathology can be associated with different underlying 
causes, but a large study [115] found no evidence for asso-
ciations between hippocampal sclerosis and lacunar infarcts, 
large infarcts, Circle of Willis atherosclerosis or CAA. How-
ever, there was a correlation between hippocampal sclerosis 
and arteriolosclerosis in multiple brain regions outside of the 
hippocampus including the frontal cortex (Brodmann area 
9) [115]. This is ascribed to a pathogenetic change in aged 
human brain arterioles that impacts multiple brain areas and 
contributes to hippocampal sclerosis of ageing [116].
Border zone and watershed infarcts
The border zone or watershed infarctions mostly occur 
from haemodynamic events, usually in patients with severe 
internal carotid artery stenosis. They could occur bilaterally 
or unilaterally and disposed to regions between two main 
arterial territories, deep and superficial vessel systems. 
Typical border zone infarctions may be 5 mm or more wide 
as wedge-shaped regions of pallor and rarefaction extend-
ing into the WM. Larger areas of incomplete infarction may 
extend into the WM [82]. These are characterised by mild 
to moderate loss of oligodendrocytes, myelin and axons in 
areas where there may be hyalinised vessels [24]. This may 
be accompanied by astrogliosis, some microgliosis and 
macrophage infiltration. The morphology of incomplete or 
subinfarctive changes, though suspected to be associated 
with cognitive function, is not consistently described in 
VaD. It may variably manifest as tissue rarefaction assessed 
by conventional stains and revealed as injury response such 
as microgliosis and astrocytosis, or the presence of other 
“reactive” cells or surrogate markers of dendritic, synaptic 
or axonal damage.
Laminar necrosis
Laminar necrosis is characterised by neuronal ischaemic 
changes leading to neuronal loss and gliosis in the cortical 
ribbon. This is particularly apparent in cases where global 
ischaemia or hypoperfusion has occurred as in cardiac 
arrest. Typical topographic distribution of spongiform 
change can be readily apparent with standard stains. They 
appear more commonly at the arterial border zones [24, 88] 
that may fall into the subtype IV of VaD pathology.
Sporadic cerebral amyloid angiopathy in VaD
CAA occurs most commonly in AD [8, 31, 70, 106], but it 
often occurs in CVD in the absence of Alzheimer pathology 
[34]. CAA is an independent substrate for cognitive impair-
ment and contributes to cognitive dysfunction [7, 131]. Tis-
sue microstructural damage caused by CAA prior to pre-
intracerebral haemorrhage is also independently associated 
with cognitive impairment [174]. The prevalence of CAA 
in VaD is not known, but it is a major cause of intracer-
ebral and lobar haemorrhages leading to profound ischae-
mic damage [138] (Fig. 6). Several familial forms of CAA 
involving ischaemic and haemorrhagic infarcts (see below) 
and cerebral hypoperfusion demonstrate the link between 
CAA and VaD. In a study of surgical biopsies exhibiting 
cerebral and cerebellar infarction, CAA was significantly 
more common in samples showing infarction than in age-
matched controls with non-vascular lesions [27]. There is 
also an association between severe CAA and cerebrovascu-
lar lesions coexisting with AD, including lacunar infarcts, 
microinfarcts and haemorrhages [43, 121, 122]. This asso-
ciation apparently is not attributable to apolipoprotein E 
(APOE) ε4 allele, as the vascular lesions correlated best 
with severity of CAA, regardless of genotype [70, 123]. 
There is also some evidence to suggest that CAA is related 
to WM changes, but not exclusively in the oldest old [160]. 
The first stroke-like episode triggers multiple cerebral 
bleeds, which is preceded by diffuse WM changes that in 
turn lead to rapid decline of cognitive functions.
Neurochemical pathology of VaD
The neurochemical basis of cognitive decline in CVD is 
poorly understood. There are few concerted studies on the 
protein and lipid chemistry of VaD. Various cellular sig-
nalling and regulatory mechanisms including apoptosis, 
autophagy, oxidative stress and inflammation are associ-
ated with VaD by virtue of their involvement in cerebral 
ischaemia or oligaemia. VaD subjects also mount a selec-
tively attenuated neuroinflammatory response [112]. It was 
reported that the monocyte chemoattractant protein-1 and 
interleukin-6 concentrations were significantly reduced 
in the frontal lobe of VaD and mixed dementia subjects, 
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suggesting that these changes had a vascular basis rather 
than due to Alzheimer pathology.
The perivascular nerve plexus [75] is highly vulner-
able, yet only few transmitter-specific changes reflecting 
neurovascular pathology have been described in subtypes 
of VaD. Selective transmitter specific changes have been 
described in some cases of VaD [87]. Two different groups 
had previously shown that compared to AD patients, cho-
line acetyltransferase activity was also reduced albeit to a 
lesser degree in the temporal cortex and hippocampus in 
patients diagnosed with multi-infarct dementia or VaD [66, 
130]. Furthermore, choline acetyltransferase activities were 
significantly reduced by 60–70 % in the frontal and tem-
poral cortices of subjects with CADASIL, which models 
SVD [92]. Choline acetyltransferase and P75 (neurotrophin 
receptor) immunoreactivities were also affected within the 
cholinergic cell bodies of the basal forebrain in CADASIL, 
but these were not so pronounced. This may depend on 
the severity of the WM degeneration [92, 107]. However, 
loss of cholinergic function is consistently greater in VaD 
patients with concurrent Alzheimer pathology [143]. Con-
versely, a novel increase in cholinergic activity in the fron-
tal cortex was revealed in infarct dementia [151].
Other studies have reported deficits in monoamines 
including dopamine and 5-hydroxytryptamine (5HT) in 
the basal ganglia and neocortex in VaD [66]. To compen-
sate for the loss [42], 5-HT(1A) and 5-HT(2A) receptors 
are likely increased in the temporal cortex in multi-infarct, 
but not subcortical VaD. Such findings, albeit fragmentary, 
reveal distinctions between the neurochemical pathology of 
VaD subtypes and suggest possibilities of pharmacologi-
cal manipulation with novel therapies in VaD. There was 
also loss of glutamatergic synapses, assessed by vesicular 
glutamate transporter 1 concentrations, in the temporal 
cortex of VaD [93], but preservation of these in the fron-
tal lobe suggests a role in sustaining cognition and protect-
ing against dementia following a stroke. However, a recent 
study has shown that the presynaptic synaptic proteins syn-
aptophysin and SNAP-25 are reduced, whereas drebrin is 
increased possibly due to decreased synaptic input in VaD 
[154]. Identification of the morphological equivalents of 
these changes in types of pyramidal cells in the frontal lobe 
would be relevant.
Pathological investigation of hereditary CAA
There are more than ten different hereditary CAAs caused 
by mutations in different genes [139, 185]. All these angi-
opathies lead to some degree of cognitive impairment or 
Table 5  Sampling of tissue and fluids for diagnosis of uncommon causes of CVD
Data adapted from several references [88, 161]. Other rare conditions with stroke injury such as syphilis, systemic vasculitides and rheumatic 
diseases may also be diagnosed from CSF
ANA antinuclear antibodies, ENA extractable nuclear antigens, CADASIL cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy, CARASIL cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy, CNS central nerv-
ous system, CSF cerebrospinal fluid, GLA galactosidase alpha, Hb haemoglobin, MTHRF methylenetetrahydrofolate reductase
Diagnostic sample Diagnostic test Target diagnoses
Tissue biopsy Arterial Temporal or giant cell arteritis, Sneddon syndrome
Cerebral meninges Primary cerebral vasculitides
Muscle CADASIL, mitochondrial diseases
Skin CADASIL, CARASIL, Sneddon syndrome, psuedoxanthoma  
elasticum and unexplained skin lesions with CNS manifestations
CSF GLA activity Fabry disease
Inflammatory cells Vasculitides, sarcoidosis, CNS infections
Serum Viral, bacterial Specific infections
ANA, ENA and anti DNA  
antibodies, complement
Systemic lupus erythematosus, connective tissue diseases
Protein electrophoresis Paraproteinaemia
Hb electrophoresis Sickle cell anaemia (HbS), thalassaemia
Serum and urine Toxicology Illicit drug use
Ammonium Glutaric acidaemia type 1 and 2, urea cycle disorders
Lactic acidosis Branch-chained organic acidurias, glutaric acidaemia  
type 1 and 2, mitochondrial diseases
Thrombophilia Antithrombin, protein C, protein S, antiphospholipid antibodies (lupus 
anticoagulant, anticardiolipin, β2-glycoprotein), homocysteine, factor 
V Leiden, prothrombin, MTHRF, factor XII
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dementia. They are characterised by multiple haemor-
rhages and haemorrhagic or ischaemic infarcts in addition 
to severe amyloid deposition within walls of the menin-
geal and intracerebral vessels. In hereditary cerebral 
haemorrhage with amyloidosis of the Dutch type, demen-
tia occurs in most patients surviving their initial stroke 
[71] and may occasionally be the presenting feature [176]. 
The extensive CAA is alone sufficient to cause dementia 
and this has implications for CAA-related cognitive dys-
function in sporadic CAA and AD [114]. In the Icelandic 
type of hereditary cerebral haemorrhage with amyloido-
sis (HCHWA-I), which is associated with a point muta-
tion in the gene encoding the cysteine protease inhibitor 
Cystatin C [101], dementia, occurring in some patients, 
has been attributed to the multiple vascular lesions. Indi-
viduals with gelsolin-related amyloidosis manifest facial 
palsy, mild peripheral neuropathy and corneal lattice dys-
trophy; atrophic bulbar palsy, gait ataxia and mild cog-
nitive impairment [94]. Familial British dementia with 
severe CAA [170] is characterised by dementia, progres-
sive spastic tetraparesis and cerebellar ataxia, the onset of 
which is usually in the sixth decade [109]. Neuropatho-
logical features also include Alzheimer-type neurofibril-
lary tangles and neuropil threads in the anteromedial tem-
poral lobe that may contribute of dementia [132, 139]. 
Familial Danish dementia (FDD), also known as heredo-
pathia ophthalmo-oto-encephalica, is another condition 
with severe and widespread CAA [171]. FDD is charac-
terised clinically by cataracts, deafness, progressive ataxia 
and dementia.
Investigation of familial small vessel diseases
Several familial stroke disorders also appear to cause cog-
nitive impairment or dementia. These can be diagnosed 
in biopsy tissues using immunohistochemical or electron 
microscopy methods (Table 5). A common feature in these 
is subcortical SVD, often characterised by severe arterio-
losclerosis in the perforating vessels [185]. Cerebral auto-
somal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) is the most common 
form of hereditary SVDs [30]. Motor deficits, an ataxic 
hemiparesis, hemianopsia and dysarthria may present as 
key neurological features akin to SVD. Vascular changes 
including apoptotic loss of brain vascular smooth muscle 
cells [68] and vessel wall thickening [37] likely reduce 
blood flow and affect the vasodilatory response to cause 
lacunar infarcts and microinfarcts in grey matter and WM 
[185]. The extensive demyelination and axonal damage in 
the underlying WM contributes to cortical atrophy [37] and 
impacting on frontal lobe cognitive functions that is con-
sistent with the disconnection of the fronto-striatal circuits 
in CADASIL. Neuronal apoptosis, predominantly in neo-
cortical layers III and V, also likely contributes to dementia 
in CADASIL [68].
The Maeda syndrome or cerebral autosomal recessive 
arteriopathy with subcortical infarcts and leukoencephalop-
athy (CARASIL) is an autosomal recessive disorder simi-
lar to CADASIL [76]. The normotensive affected subjects 
exhibit not only severe arteriolosclerosis, leukoencepha-
lopathy and lacunar infarcts, but also spinal anomalies and 
alopecia. Strokes lead to stepwise deterioration with most 
subjects becoming demented in older age. Familial cerebral 
SVDs involving progressive visual impairment [185] cause 
deterioration in cognitive function. Hereditary endotheli-
opathy with retinopathy, nephropathy and stroke (HERNS), 
cerebroretinal vasculopathy (CRV) and hereditary vascular 
retinopathy (HVR) were reported independently, but repre-
sent different phenotypes in the same disease spectrum [85, 
124, 162]. These, now described as autosomal dominant 
retinal vasculopathy with cerebral leukodystrophy, lead 
to early death and cause dementia. Retinal microvessels 
undergo severe distortions and become tortuous, predictive 
of the SVD type of pathology with multilaminated vascular 
basement membranes in the brain [85].
Some rarer and less characterised hereditary SVDs 
(Table 1) also exist that are associated with clinical SVD 
features and different degrees of cognitive impairment, but 
the pathologies in these are not described. They include 
conditions with abnormalities in the skin and eye and mul-
tiple lacunar infarcts in the deep WM and pons [128], reti-
nal arteriolar tortuosity and leukoencephalopathy [67, 166] 
and profound WM changes upon MRI [169].
Summary
Defining the neuropathological substrates of VaD relies on 
uniformity in sampling and careful pathological examina-
tion. VaD resulting from severe VCI or vascular cognitive 
disorder or from delayed impairment after stroke appears 
to result from the accumulation of several lesions includ-
ing cerebral atrophy. While robust neuropathological cri-
teria for VaD are still being developed, multiple microin-
farcts, small infarcts or lacunes in the subcortical structures 
rather than macroinfarction or large vessel disease appear 
most robustly related to cognitive impairment. Diffuse 
WM changes involving periventricular and deeper regions 
are frequent in VaD. Concomitant hippocampal pathology 
including sclerosis and Alzheimer pathology compound 
disease progression. Further definitions of the neuropatho-
logical correlates of VaD and investigation of genetic mod-
els would be valuable for exploring the pathogenesis as 
well as management of VaD through preventative and treat-
ment strategies.
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